Edition 28 – Legal Obstacles to Biosimilar Market Entry

Legal Obstacles to Biosimilar Market Entry By Laura Karas, MD, MPH; Rachel Sachs, JD, MPH; Gerard Anderson, PhD Citation Karas L, Sachs R, Anderson G. Legal obstacles to biosimilar market entry. HPHR. 2021;28.  Legal Obstacles to Biosimilar Market Entry Abstract Improving the market availability and penetration of biosimilars, “follow-on” versions of biologic products, will require […]